Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Everett E. Vokes

Concepts (652)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
106
2022
1007
17.520
Why?
Lung Neoplasms
146
2022
2125
15.290
Why?
Carcinoma, Non-Small-Cell Lung
103
2022
986
15.270
Why?
Antineoplastic Combined Chemotherapy Protocols
126
2022
2318
15.220
Why?
Carcinoma, Squamous Cell
75
2021
1036
9.910
Why?
Chemoradiotherapy
32
2022
290
5.980
Why?
Antineoplastic Agents
75
2022
2364
5.900
Why?
Neoplasm Recurrence, Local
50
2022
1189
5.020
Why?
Papillomavirus Infections
12
2022
196
4.410
Why?
Small Cell Lung Carcinoma
20
2021
85
4.020
Why?
Carboplatin
40
2022
272
3.790
Why?
Combined Modality Therapy
63
2021
1683
3.530
Why?
Oropharyngeal Neoplasms
8
2022
118
3.460
Why?
Quinazolines
22
2015
220
3.390
Why?
Protein Kinase Inhibitors
21
2020
566
3.380
Why?
Paclitaxel
40
2022
464
3.200
Why?
Aged
187
2021
18556
3.160
Why?
Neoplasm Staging
74
2022
1930
2.940
Why?
Disease-Free Survival
57
2020
1198
2.830
Why?
Middle Aged
189
2022
25658
2.760
Why?
Humans
325
2022
83704
2.740
Why?
Aged, 80 and over
100
2021
6594
2.490
Why?
Male
206
2022
42001
2.420
Why?
Survival Rate
54
2021
1923
2.390
Why?
Female
208
2022
44883
2.320
Why?
Adult
153
2022
26064
2.250
Why?
Clinical Trials as Topic
24
2021
1201
2.230
Why?
Papillomaviridae
9
2022
141
2.220
Why?
Treatment Outcome
88
2022
7922
2.120
Why?
Cisplatin
31
2022
582
2.110
Why?
Adenocarcinoma
24
2016
1196
2.050
Why?
Induction Chemotherapy
12
2022
138
2.040
Why?
Carcinoma, Small Cell
11
2017
140
1.940
Why?
Taxoids
17
2017
131
1.920
Why?
Survival Analysis
45
2020
1589
1.920
Why?
Indoles
15
2017
335
1.870
Why?
Camptothecin
14
2013
195
1.820
Why?
Radiotherapy Dosage
30
2021
480
1.720
Why?
Antibodies, Monoclonal
20
2021
1524
1.690
Why?
Radiotherapy
15
2011
339
1.650
Why?
Pyrroles
7
2017
220
1.620
Why?
Fluorouracil
25
2014
563
1.610
Why?
Radiation-Sensitizing Agents
6
2013
102
1.580
Why?
Mesothelioma
13
2017
296
1.490
Why?
Hydroxyurea
20
2014
230
1.460
Why?
Laryngeal Neoplasms
5
2013
86
1.420
Why?
Chemotherapy, Adjuvant
20
2015
468
1.410
Why?
Drug Resistance, Neoplasm
13
2021
579
1.390
Why?
Deoxycytidine
14
2012
241
1.380
Why?
Mouth Neoplasms
9
2018
181
1.370
Why?
Angiogenesis Inhibitors
9
2016
292
1.340
Why?
Benzimidazoles
4
2021
137
1.320
Why?
Prognosis
47
2022
3716
1.310
Why?
Etoposide
15
2021
198
1.310
Why?
Proto-Oncogene Proteins c-met
16
2021
202
1.310
Why?
Sirolimus
3
2020
171
1.270
Why?
Medical Oncology
7
2021
332
1.200
Why?
Salvage Therapy
9
2014
224
1.090
Why?
Guanine
8
2014
208
1.040
Why?
Maximum Tolerated Dose
13
2018
270
1.010
Why?
Esophageal Neoplasms
5
2012
347
1.010
Why?
Quality of Life
16
2017
1373
0.990
Why?
Clinical Trials, Phase II as Topic
8
2017
171
0.970
Why?
Deglutition
9
2020
68
0.970
Why?
Clinical Trials, Phase III as Topic
10
2021
163
0.970
Why?
Antibodies, Monoclonal, Humanized
18
2018
942
0.970
Why?
Liver Neoplasms
8
2018
636
0.960
Why?
Vascular Endothelial Growth Factor A
10
2013
383
0.960
Why?
Randomized Controlled Trials as Topic
12
2021
862
0.950
Why?
Neoplasms, Second Primary
8
2011
251
0.950
Why?
Pancreatic Neoplasms
4
2010
674
0.930
Why?
Radiotherapy, Conformal
5
2011
87
0.920
Why?
Immunotherapy
6
2021
583
0.910
Why?
Drug Monitoring
2
2022
121
0.900
Why?
Kaplan-Meier Estimate
17
2017
899
0.890
Why?
Disease Progression
22
2021
1474
0.870
Why?
DNA, Viral
1
2022
282
0.870
Why?
Pleural Neoplasms
5
2020
183
0.870
Why?
Neoplasm Metastasis
19
2020
1052
0.870
Why?
Molecular Targeted Therapy
3
2020
273
0.860
Why?
Cyclooxygenase 2
4
2017
97
0.840
Why?
Carcinoma
8
2022
441
0.840
Why?
Carcinoma, Large Cell
7
2014
41
0.830
Why?
Thoracic Neoplasms
4
2018
60
0.780
Why?
Enzyme Inhibitors
7
2014
674
0.780
Why?
Costs and Cost Analysis
1
2019
153
0.750
Why?
Glutamates
6
2014
93
0.730
Why?
Neoplasms
16
2021
2709
0.720
Why?
Terminal Care
1
2019
139
0.710
Why?
Vinblastine
3
2002
109
0.710
Why?
Drug Administration Schedule
17
2020
973
0.690
Why?
Organoplatinum Compounds
4
2006
99
0.690
Why?
Radiotherapy, Adjuvant
12
2015
308
0.690
Why?
Stomach Neoplasms
3
2011
263
0.660
Why?
Follow-Up Studies
24
2021
3881
0.650
Why?
Time Factors
21
2021
5506
0.650
Why?
Peritoneal Neoplasms
4
2012
179
0.650
Why?
Human papillomavirus 16
2
2015
36
0.650
Why?
Quality of Health Care
2
2019
366
0.650
Why?
Intracellular Signaling Peptides and Proteins
3
2014
384
0.640
Why?
Colorectal Neoplasms
5
2011
859
0.640
Why?
Thionucleotides
2
2008
59
0.630
Why?
Neoadjuvant Therapy
7
2022
272
0.630
Why?
Organ Sparing Treatments
2
2013
35
0.620
Why?
Adenocarcinoma, Bronchiolo-Alveolar
3
2011
20
0.610
Why?
Neoplasms, Squamous Cell
2
2015
19
0.610
Why?
Receptor Protein-Tyrosine Kinases
5
2015
161
0.600
Why?
Speech
2
2013
72
0.590
Why?
Exanthema
3
2014
32
0.580
Why?
Remission Induction
10
2014
716
0.570
Why?
Patient Selection
8
2021
700
0.570
Why?
Platinum Compounds
3
2022
31
0.550
Why?
Pyridines
5
2019
309
0.530
Why?
Neck Dissection
6
2010
72
0.520
Why?
Blood Proteins
1
2014
160
0.520
Why?
Neutropenia
6
2017
223
0.490
Why?
Neoplasm Invasiveness
6
2016
532
0.490
Why?
DNA Repair
2
2014
351
0.490
Why?
Radiotherapy, Intensity-Modulated
5
2016
171
0.480
Why?
Platinum
7
2022
58
0.480
Why?
Cell Line, Tumor
20
2021
2434
0.480
Why?
Mutation
16
2017
3872
0.470
Why?
Proteomics
1
2014
191
0.470
Why?
Publishing
1
2013
90
0.470
Why?
Protein-Tyrosine Kinases
6
2017
308
0.470
Why?
Healthcare Disparities
1
2016
339
0.470
Why?
Antimetabolites, Antineoplastic
4
2013
250
0.460
Why?
Sulfonamides
9
2014
329
0.460
Why?
DNA-Binding Proteins
3
2015
1212
0.460
Why?
Radiosurgery
3
2021
256
0.450
Why?
Retrospective Studies
25
2021
7701
0.450
Why?
Proto-Oncogene Proteins c-cbl
3
2017
36
0.450
Why?
Lung
3
2013
1067
0.440
Why?
Receptors, Growth Factor
5
2011
56
0.430
Why?
Nasopharyngeal Neoplasms
3
2016
44
0.430
Why?
Alphapapillomavirus
2
2021
38
0.430
Why?
Gene Expression Regulation, Neoplastic
11
2017
1210
0.430
Why?
Proportional Hazards Models
9
2019
872
0.430
Why?
Area Under Curve
6
2018
345
0.420
Why?
Signal Transduction
11
2019
3309
0.420
Why?
Antineoplastic Agents, Phytogenic
5
2012
298
0.420
Why?
Maintenance Chemotherapy
3
2020
77
0.400
Why?
Methotrexate
2
2017
263
0.400
Why?
Receptor, EphB4
3
2015
27
0.400
Why?
Age Factors
7
2018
1919
0.390
Why?
Carmustine
2
2006
72
0.390
Why?
Immunoconjugates
2
2021
114
0.380
Why?
Piperazines
8
2019
270
0.380
Why?
O(6)-Methylguanine-DNA Methyltransferase
2
2006
118
0.380
Why?
Administration, Oral
9
2020
727
0.380
Why?
Dose-Response Relationship, Drug
14
2018
2100
0.380
Why?
Arsenicals
1
2008
42
0.370
Why?
Cohort Studies
10
2021
2715
0.370
Why?
Oxides
1
2008
49
0.370
Why?
Proto-Oncogene Proteins
5
2017
678
0.370
Why?
Fatigue
3
2018
169
0.360
Why?
Salivary Gland Neoplasms
4
2011
60
0.360
Why?
Prostatic Neoplasms
5
2011
1486
0.360
Why?
Smoking
6
2014
569
0.360
Why?
Infusions, Intravenous
8
2018
448
0.360
Why?
Double-Blind Method
5
2017
1906
0.350
Why?
Immunohistochemistry
10
2020
1824
0.350
Why?
Indazoles
4
2013
71
0.350
Why?
International Cooperation
3
2018
135
0.350
Why?
Deglutition Disorders
4
2011
82
0.340
Why?
Consolidation Chemotherapy
2
2018
21
0.340
Why?
Suramin
2
2004
27
0.330
Why?
Alkyl and Aryl Transferases
2
2003
15
0.330
Why?
Prospective Studies
12
2022
4099
0.330
Why?
Lymph Nodes
5
2019
535
0.330
Why?
Phosphorylcholine
1
2006
25
0.320
Why?
Pyrimidines
4
2012
402
0.320
Why?
Niacinamide
5
2013
117
0.320
Why?
DNA
1
2012
1306
0.320
Why?
Young Adult
10
2022
5983
0.320
Why?
Thiazoles
3
2012
130
0.320
Why?
Anemia
4
2017
127
0.310
Why?
Multivariate Analysis
8
2019
1012
0.310
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2021
102
0.310
Why?
Risk Factors
12
2018
5433
0.310
Why?
Benzenesulfonates
3
2010
64
0.310
Why?
Gene Rearrangement
2
2017
169
0.310
Why?
Tubulin Modulators
2
2021
28
0.310
Why?
High-Throughput Nucleotide Sequencing
2
2020
417
0.310
Why?
Gallbladder Neoplasms
1
2005
28
0.310
Why?
Practice Guidelines as Topic
3
2016
1087
0.300
Why?
Mouth
2
2018
54
0.300
Why?
Dacarbazine
1
2006
113
0.300
Why?
Research Design
4
2015
569
0.300
Why?
Placebos
5
2015
233
0.300
Why?
Proto-Oncogene Proteins c-bcl-2
3
2010
200
0.290
Why?
Neovascularization, Pathologic
2
2008
356
0.290
Why?
Bile Duct Neoplasms
1
2005
70
0.290
Why?
Antineoplastic Agents, Alkylating
1
2005
146
0.290
Why?
Confidence Intervals
5
2018
233
0.280
Why?
Boronic Acids
3
2011
55
0.280
Why?
Oligopeptides
1
2005
186
0.280
Why?
Imidazoles
4
2013
168
0.280
Why?
Radiation Dosage
3
2020
227
0.270
Why?
Pneumonectomy
3
2018
186
0.270
Why?
Pyrazines
3
2011
86
0.270
Why?
Mouthwashes
1
2003
5
0.270
Why?
Cyclosporine
1
2005
253
0.270
Why?
Xenograft Model Antitumor Assays
7
2017
464
0.270
Why?
Sarcoma
1
2006
215
0.270
Why?
Feasibility Studies
4
2022
759
0.270
Why?
United States
12
2022
6355
0.270
Why?
Positron-Emission Tomography
2
2018
273
0.270
Why?
Radiography
4
2014
876
0.270
Why?
Viral Vaccines
1
2003
41
0.260
Why?
Tretinoin
2
2021
126
0.260
Why?
Cancer Care Facilities
1
2003
26
0.260
Why?
Immunoblotting
5
2017
279
0.260
Why?
Travel
1
2003
66
0.260
Why?
Quinolones
1
2003
57
0.250
Why?
Tongue Neoplasms
3
2018
52
0.250
Why?
Gene Expression
5
2017
1333
0.240
Why?
Phosphorylation
7
2017
1159
0.240
Why?
Drug Eruptions
2
2017
38
0.240
Why?
Attitude to Health
1
2004
224
0.240
Why?
Cranial Irradiation
3
2018
36
0.240
Why?
TOR Serine-Threonine Kinases
3
2020
181
0.240
Why?
Brain Neoplasms
3
2012
807
0.240
Why?
Precancerous Conditions
1
2003
206
0.230
Why?
Chicago
4
2014
1454
0.230
Why?
Thrombocytopenia
2
2017
171
0.230
Why?
Receptors, Vascular Endothelial Growth Factor
3
2010
62
0.230
Why?
Melanoma
2
2005
515
0.220
Why?
Erythroid Precursor Cells
1
2021
32
0.220
Why?
Focal Adhesions
2
2013
69
0.220
Why?
Research Report
1
2021
43
0.220
Why?
Genomics
3
2016
648
0.220
Why?
Polymorphism, Genetic
4
2011
821
0.220
Why?
Paxillin
2
2013
61
0.210
Why?
Pyrrolidinones
1
2020
17
0.210
Why?
RNA, Small Interfering
8
2017
568
0.210
Why?
Sex Factors
4
2019
1090
0.210
Why?
Topoisomerase I Inhibitors
5
2013
36
0.200
Why?
Aminopyridines
1
2019
30
0.200
Why?
Morpholines
1
2019
80
0.200
Why?
Mucositis
2
2017
22
0.200
Why?
Quinolines
1
2020
98
0.200
Why?
Immunosuppressive Agents
1
2005
1027
0.190
Why?
Survival
3
2003
23
0.190
Why?
Predictive Value of Tests
4
2020
1766
0.190
Why?
Pharynx
1
2018
38
0.190
Why?
Epothilones
2
2009
13
0.190
Why?
Granulocyte Colony-Stimulating Factor
4
2011
167
0.190
Why?
Hepatocyte Growth Factor
3
2014
83
0.190
Why?
Phenylurea Compounds
4
2013
110
0.190
Why?
Erythropoietin
3
2013
92
0.190
Why?
Adolescent
6
2022
9178
0.190
Why?
Vascular Endothelial Growth Factor Receptor-2
3
2009
80
0.180
Why?
Radiation Injuries
2
2018
161
0.180
Why?
Health Resources
1
2019
79
0.180
Why?
Depsipeptides
2
2010
30
0.180
Why?
Gene Dosage
7
2013
216
0.180
Why?
Orthodontic Appliances
1
2018
8
0.180
Why?
Dental Alloys
1
2018
7
0.180
Why?
Radiation Pneumonitis
1
2018
16
0.180
Why?
Hemoptysis
1
2018
24
0.180
Why?
DNA Topoisomerases, Type I
3
2013
28
0.180
Why?
Tumor Microenvironment
2
2021
325
0.180
Why?
Radiotherapy Planning, Computer-Assisted
3
2018
190
0.180
Why?
Skin Neoplasms
2
2005
542
0.180
Why?
Macrophages
1
2021
562
0.180
Why?
Mice
11
2021
11173
0.170
Why?
Vision Disorders
1
2018
69
0.170
Why?
Transforming Growth Factor alpha
2
2009
52
0.170
Why?
Retreatment
3
2012
106
0.170
Why?
Gene Expression Profiling
4
2021
1373
0.170
Why?
Genotype
5
2015
1856
0.170
Why?
Carcinoma, Renal Cell
3
2007
402
0.170
Why?
Mice, Nude
4
2012
786
0.170
Why?
Odds Ratio
4
2008
683
0.170
Why?
Tomography, X-Ray Computed
4
2013
2572
0.170
Why?
Intention to Treat Analysis
1
2017
69
0.170
Why?
Geriatric Assessment
1
2018
158
0.170
Why?
Animals
14
2021
27044
0.170
Why?
Pyrazoles
3
2011
168
0.170
Why?
Life Style
1
2018
191
0.160
Why?
In Situ Hybridization, Fluorescence
4
2012
359
0.160
Why?
Patient Acceptance of Health Care
1
2019
220
0.160
Why?
Paired Box Transcription Factors
2
2014
51
0.160
Why?
Carcinoma, Adenoid Cystic
2
2007
23
0.160
Why?
Statistics, Nonparametric
3
2009
326
0.160
Why?
Probability
3
2008
360
0.160
Why?
Lymphatic Metastasis
4
2014
508
0.160
Why?
SEER Program
1
2016
193
0.150
Why?
Kidney Neoplasms
3
2007
595
0.150
Why?
Recombinant Proteins
5
2010
1064
0.150
Why?
Cell Movement
6
2017
745
0.150
Why?
Fractals
1
2015
45
0.150
Why?
Endpoint Determination
1
2015
60
0.150
Why?
Antibody-Dependent Cell Cytotoxicity
1
2015
25
0.150
Why?
Bryostatins
2
2006
15
0.150
Why?
Platelet-Derived Growth Factor
2
2011
68
0.140
Why?
Cell Proliferation
8
2015
1619
0.140
Why?
Injections, Intravenous
2
2006
269
0.140
Why?
Health Status
2
2009
365
0.140
Why?
Radiation, Ionizing
2
2012
126
0.140
Why?
Receptors, Antigen, T-Cell
1
2017
399
0.140
Why?
Incidence
5
2018
1644
0.140
Why?
Isotretinoin
2
2006
22
0.140
Why?
Gene Knockout Techniques
1
2014
75
0.140
Why?
Mass Screening
2
2013
626
0.140
Why?
Treatment Failure
5
2010
303
0.140
Why?
Preoperative Care
3
2009
418
0.140
Why?
Tumor Virus Infections
1
2014
82
0.140
Why?
Socioeconomic Factors
1
2016
584
0.130
Why?
Cell Survival
5
2017
1015
0.130
Why?
Cyclooxygenase 2 Inhibitors
2
2017
34
0.130
Why?
Gene Amplification
2
2018
134
0.130
Why?
Population Groups
1
2013
42
0.130
Why?
Farnesyltranstransferase
2
2003
6
0.130
Why?
Forecasting
2
2021
323
0.130
Why?
Risk Assessment
7
2016
2288
0.130
Why?
Hypopharyngeal Neoplasms
1
2013
15
0.130
Why?
Erythropoiesis
1
2013
50
0.130
Why?
Glucuronosyltransferase
2
2006
188
0.130
Why?
Leukocytes, Mononuclear
2
2005
200
0.130
Why?
Interferon-alpha
3
2010
239
0.130
Why?
Alcohol Drinking
3
2018
275
0.130
Why?
Clinical Protocols
1
2013
157
0.130
Why?
Dehydration
1
2013
23
0.130
Why?
Esophagitis
1
2013
42
0.130
Why?
Pharmacogenetics
2
2008
410
0.130
Why?
Gene Deletion
1
2014
346
0.130
Why?
HeLa Cells
1
2014
512
0.130
Why?
Killer Cells, Natural
1
2015
306
0.120
Why?
Osteoradionecrosis
2
2010
14
0.120
Why?
Universities
2
2010
134
0.120
Why?
Keratin-19
1
2012
11
0.120
Why?
Ketones
1
2012
12
0.120
Why?
Furans
1
2012
18
0.120
Why?
Dexamethasone
2
2004
314
0.120
Why?
Radiation Tolerance
2
2021
175
0.120
Why?
Arachidonate 5-Lipoxygenase
1
2011
23
0.120
Why?
DNA Mutational Analysis
5
2017
539
0.120
Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2012
48
0.120
Why?
Prostate-Specific Antigen
2
2004
313
0.120
Why?
Phthalazines
1
2011
30
0.120
Why?
Ovarian Neoplasms
2
2008
686
0.120
Why?
Genetic Testing
1
2016
502
0.120
Why?
Evidence-Based Medicine
2
2007
454
0.120
Why?
Cancer Vaccines
1
2013
157
0.110
Why?
RNA, Viral
1
2013
345
0.110
Why?
Image Processing, Computer-Assisted
2
2015
1180
0.110
Why?
Organ Preservation
1
2011
69
0.110
Why?
Radiotherapy, Image-Guided
1
2012
62
0.110
Why?
Genes, ras
1
2011
99
0.110
Why?
Neoplastic Cells, Circulating
1
2011
71
0.110
Why?
Periodicals as Topic
1
2013
168
0.110
Why?
Rad51 Recombinase
2
2014
81
0.110
Why?
Receptor, EphA2
1
2010
6
0.110
Why?
Mucins
1
2010
44
0.110
Why?
Community Networks
2
2018
35
0.110
Why?
Analysis of Variance
3
2011
963
0.110
Why?
Oncogene Proteins, Fusion
1
2011
123
0.100
Why?
Developing Countries
1
2010
73
0.100
Why?
Carcinosarcoma
1
2010
20
0.100
Why?
Antibiotics, Antineoplastic
1
2010
122
0.100
Why?
Health Facilities
1
2009
27
0.100
Why?
Antigens, Neoplasm
1
2012
330
0.100
Why?
Tissue Array Analysis
3
2017
128
0.100
Why?
Postoperative Period
1
2010
312
0.100
Why?
ras Proteins
1
2010
133
0.100
Why?
Biliary Tract Neoplasms
1
2009
32
0.100
Why?
Diarrhea
3
2008
208
0.100
Why?
Disease Models, Animal
4
2021
2309
0.100
Why?
Postoperative Complications
2
2018
2266
0.100
Why?
Hematopoietic Stem Cells
1
2011
287
0.100
Why?
Mesna
1
2008
10
0.100
Why?
Radiotherapy, High-Energy
1
2008
50
0.100
Why?
Receptor, erbB-2
2
2011
193
0.090
Why?
Proto-Oncogene Proteins c-akt
2
2010
320
0.090
Why?
Gene Knockdown Techniques
3
2017
244
0.090
Why?
Macrolides
2
2012
32
0.090
Why?
Radiotherapy, Computer-Assisted
1
2008
25
0.090
Why?
Enteral Nutrition
2
2020
107
0.090
Why?
Patient Care
1
2009
88
0.090
Why?
Eicosanoids
1
2008
16
0.090
Why?
Skin
1
2012
560
0.090
Why?
Lipoxygenase Inhibitors
1
2008
34
0.090
Why?
Mutation, Missense
1
2010
278
0.090
Why?
Fallopian Tube Neoplasms
1
2008
36
0.090
Why?
Lymphoma, Non-Hodgkin
1
2010
265
0.090
Why?
Pain
2
2017
363
0.090
Why?
Pneumonia, Aspiration
1
2007
19
0.090
Why?
Technology, Radiologic
1
2008
102
0.090
Why?
Tumor Suppressor Protein p53
1
2010
370
0.090
Why?
Hypertension
1
2017
1210
0.090
Why?
Azacitidine
1
2008
122
0.090
Why?
Lung Diseases
1
2009
269
0.090
Why?
Tumor Burden
3
2013
288
0.090
Why?
Epidermal Growth Factor
1
2007
123
0.080
Why?
Protein Kinase C
1
2008
301
0.080
Why?
Models, Biological
2
2015
1798
0.080
Why?
Regression Analysis
1
2009
628
0.080
Why?
Tongue
1
2007
57
0.080
Why?
Oncogenes
1
2007
90
0.080
Why?
Multienzyme Complexes
2
2004
66
0.080
Why?
Triazines
1
2007
48
0.080
Why?
Uterine Neoplasms
1
2010
184
0.080
Why?
Cysteine Endopeptidases
2
2004
91
0.080
Why?
DNA Primers
3
2014
571
0.080
Why?
Immunologic Factors
1
2008
165
0.080
Why?
Proteasome Endopeptidase Complex
2
2004
103
0.080
Why?
Tachycardia, Supraventricular
1
2006
21
0.080
Why?
Gastrointestinal Stromal Tumors
1
2006
26
0.080
Why?
Genes, Tumor Suppressor
1
2007
165
0.080
Why?
Neoplasms, Hormone-Dependent
1
2006
39
0.080
Why?
p38 Mitogen-Activated Protein Kinases
1
2006
119
0.080
Why?
Activin Receptors, Type I
1
2005
12
0.080
Why?
Leiomyosarcoma
1
2006
35
0.080
Why?
Base Sequence
4
2014
2431
0.080
Why?
Observation
2
2020
39
0.080
Why?
Phospholipids
1
2006
127
0.080
Why?
Illinois
2
2007
472
0.080
Why?
Surgical Flaps
1
2008
259
0.080
Why?
Receptors, Transforming Growth Factor beta
1
2005
42
0.080
Why?
Anticarcinogenic Agents
1
2006
73
0.080
Why?
Physician's Role
1
2007
187
0.080
Why?
Societies, Medical
2
2007
577
0.080
Why?
Programmed Cell Death 1 Receptor
2
2019
167
0.080
Why?
Carbon Monoxide
1
2005
92
0.070
Why?
Adaptor Proteins, Signal Transducing
1
2007
304
0.070
Why?
Cholangiocarcinoma
1
2005
57
0.070
Why?
Interleukin-2
1
2006
287
0.070
Why?
Otorhinolaryngologic Surgical Procedures
1
2005
15
0.070
Why?
Proto-Oncogene Proteins c-kit
1
2005
82
0.070
Why?
Algorithms
3
2013
1850
0.070
Why?
Drug Interactions
1
2005
271
0.070
Why?
Hemorrhage
1
2006
249
0.070
Why?
Radiometry
1
2004
49
0.070
Why?
Reconstructive Surgical Procedures
1
2008
274
0.070
Why?
Speech Intelligibility
1
2004
10
0.070
Why?
Voice
1
2004
12
0.070
Why?
Dose-Response Relationship, Radiation
2
2018
201
0.070
Why?
Leukemia
1
2006
301
0.070
Why?
Oligonucleotides, Antisense
1
2004
69
0.070
Why?
Pyrrolidines
1
2004
58
0.070
Why?
Case-Control Studies
2
2006
1828
0.070
Why?
Taste
1
2004
27
0.070
Why?
Loss of Heterozygosity
2
2017
87
0.070
Why?
Multicenter Studies as Topic
1
2004
155
0.070
Why?
Administration, Topical
1
2003
98
0.070
Why?
Logistic Models
3
2018
1165
0.070
Why?
Fibroblast Growth Factors
1
2004
83
0.070
Why?
Protease Inhibitors
1
2004
74
0.070
Why?
Nausea
1
2005
169
0.070
Why?
Carcinoma, Transitional Cell
1
2005
156
0.070
Why?
Biopsy, Needle
1
2004
268
0.070
Why?
Thyroid Neoplasms
1
2008
439
0.070
Why?
Vomiting
1
2005
186
0.070
Why?
Mitogen-Activated Protein Kinase 3
1
2003
72
0.060
Why?
Intubation, Gastrointestinal
1
2003
31
0.060
Why?
Amino Acid Sequence
3
2015
2175
0.060
Why?
DNA Methylation
1
2008
580
0.060
Why?
Mastication
1
2004
67
0.060
Why?
Lactones
1
2003
33
0.060
Why?
Premedication
1
2003
58
0.060
Why?
Bone Neoplasms
1
2006
326
0.060
Why?
In Situ Hybridization
1
2003
324
0.060
Why?
Cell Transformation, Neoplastic
1
2005
410
0.060
Why?
Hospitals, University
1
2003
203
0.060
Why?
Contrast Media
2
2009
1084
0.060
Why?
Mouth Mucosa
1
2003
72
0.060
Why?
Oligonucleotide Array Sequence Analysis
3
2010
703
0.060
Why?
Antineoplastic Agents, Hormonal
1
2004
153
0.060
Why?
Cause of Death
1
2004
279
0.060
Why?
STAT3 Transcription Factor
2
2013
71
0.060
Why?
Adenoviridae
1
2003
348
0.060
Why?
Drug Therapy, Combination
2
2019
992
0.060
Why?
Patient Care Team
1
2005
275
0.060
Why?
Carcinoma, Hepatocellular
1
2005
320
0.060
Why?
Mitogen-Activated Protein Kinases
1
2003
233
0.060
Why?
RNA Interference
2
2017
378
0.060
Why?
Registries
1
2006
667
0.060
Why?
Education, Medical, Continuing
1
2003
104
0.060
Why?
Interleukin-6
1
2003
237
0.060
Why?
Receptors, CCR2
1
2021
34
0.060
Why?
Pilot Projects
2
2019
836
0.060
Why?
Adaptation, Psychological
1
2002
156
0.060
Why?
DNA Damage
2
2014
357
0.050
Why?
Referral and Consultation
1
2003
326
0.050
Why?
Apoptosis
3
2014
1782
0.050
Why?
Glucocorticoids
1
2003
361
0.050
Why?
Protein Structure, Tertiary
2
2015
767
0.050
Why?
Comorbidity
1
2004
940
0.050
Why?
Clinical Trials, Phase I as Topic
2
2011
148
0.050
Why?
T-Lymphocytes
2
2006
1301
0.050
Why?
Adaptive Immunity
1
2021
163
0.050
Why?
Interferon-gamma
1
2021
462
0.050
Why?
Infant
1
2006
3118
0.050
Why?
Tumor Necrosis Factor-alpha
1
2003
696
0.050
Why?
Sulindac
2
2009
11
0.050
Why?
CD4-Positive T-Lymphocytes
1
2021
400
0.050
Why?
Oral Health
1
2018
10
0.050
Why?
Activities of Daily Living
1
2019
190
0.040
Why?
Age of Onset
1
2018
320
0.040
Why?
CD8-Positive T-Lymphocytes
1
2021
516
0.040
Why?
Cooperative Behavior
2
2009
170
0.040
Why?
Social Participation
1
2017
13
0.040
Why?
Models, Molecular
2
2015
1310
0.040
Why?
Anorexia
1
2017
29
0.040
Why?
Metals
1
2018
91
0.040
Why?
Sensation Disorders
1
2017
21
0.040
Why?
African Americans
1
2005
1168
0.040
Why?
Transfection
2
2010
946
0.040
Why?
Nerve Tissue Proteins
1
2021
530
0.040
Why?
Dinoprostone
1
2017
70
0.040
Why?
Transcriptome
1
2021
520
0.040
Why?
Proteolysis
1
2017
99
0.040
Why?
Weight Loss
1
2019
234
0.040
Why?
Dyspnea
1
2017
80
0.040
Why?
ROC Curve
1
2019
763
0.040
Why?
Bronchoscopy
1
2017
149
0.040
Why?
Decision Making
1
2002
619
0.040
Why?
Polymerase Chain Reaction
2
2009
1000
0.040
Why?
Mice, Knockout
1
2021
1962
0.040
Why?
Analgesics, Opioid
1
2020
374
0.040
Why?
Cell Line
2
2011
2617
0.040
Why?
Molecular Sequence Annotation
1
2015
76
0.040
Why?
Receptors, IgG
1
2015
51
0.040
Why?
Thalidomide
1
2015
54
0.040
Why?
Breast Neoplasms
2
2005
2784
0.040
Why?
Human papillomavirus 18
1
2014
15
0.040
Why?
Safety
2
2008
174
0.040
Why?
Protein Interaction Maps
1
2014
50
0.030
Why?
Sequence Alignment
1
2015
366
0.030
Why?
Erythrocyte Count
1
2013
23
0.030
Why?
Biopsy
2
2009
1182
0.030
Why?
Genes, BRCA2
1
2014
147
0.030
Why?
Autopsy
1
2013
109
0.030
Why?
DNA Copy Number Variations
1
2014
178
0.030
Why?
Genes, BRCA1
1
2014
187
0.030
Why?
Gastrostomy
1
2013
76
0.030
Why?
Sequence Analysis, RNA
1
2014
204
0.030
Why?
Immunoglobulin G
1
2015
483
0.030
Why?
Drug Synergism
1
2013
335
0.030
Why?
Ethers, Cyclic
1
2012
7
0.030
Why?
Herpesvirus 4, Human
1
2013
115
0.030
Why?
Macrophage Colony-Stimulating Factor
1
2012
19
0.030
Why?
Germ-Line Mutation
1
2015
297
0.030
Why?
Thrombospondin 1
1
2011
22
0.030
Why?
GPI-Linked Proteins
1
2011
55
0.030
Why?
Enzyme Activation
1
2013
737
0.030
Why?
Alleles
2
2006
1117
0.030
Why?
Caenorhabditis elegans
1
2014
209
0.030
Why?
Immunoenzyme Techniques
1
2012
331
0.030
Why?
Magnetic Resonance Imaging
1
2004
3276
0.030
Why?
Drug Dosage Calculations
1
2011
17
0.030
Why?
California
1
2011
135
0.030
Why?
Chemoradiotherapy, Adjuvant
1
2011
34
0.030
Why?
Computational Biology
1
2015
530
0.030
Why?
Lymphopenia
1
2011
31
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2012
286
0.030
Why?
Thorax
1
2011
52
0.030
Why?
src-Family Kinases
1
2011
76
0.030
Why?
Organs at Risk
1
2011
46
0.030
Why?
Barrett Esophagus
1
2012
132
0.030
Why?
DNA Breaks, Double-Stranded
1
2011
54
0.030
Why?
Gene Regulatory Networks
1
2013
283
0.030
Why?
HEK293 Cells
1
2013
646
0.030
Why?
Cyclin D1
1
2010
81
0.030
Why?
Endonucleases
1
2010
21
0.030
Why?
Lymphoma, Mantle-Cell
1
2010
32
0.030
Why?
Leucovorin
1
2010
219
0.030
Why?
National Cancer Institute (U.S.)
1
2010
64
0.030
Why?
Histone Deacetylases
1
2010
61
0.030
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
119
0.030
Why?
Hospitals, Veterans
1
2009
19
0.030
Why?
Lymphoma, Follicular
1
2010
68
0.030
Why?
Paraffin Embedding
1
2010
77
0.030
Why?
Clinical Trials Data Monitoring Committees
1
2009
6
0.030
Why?
Chromosomes, Human, Pair 11
1
2010
108
0.030
Why?
Peptides
1
2013
642
0.030
Why?
Semaphorins
1
2009
17
0.030
Why?
Hydroxamic Acids
1
2009
48
0.030
Why?
Molecular Sequence Data
1
2015
3194
0.030
Why?
Proto-Oncogene Proteins p21(ras)
1
2010
143
0.030
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2010
130
0.030
Why?
Lymphoma, Large B-Cell, Diffuse
1
2010
125
0.020
Why?
Wound Healing
1
2012
350
0.020
Why?
Mutagenesis, Site-Directed
1
2010
282
0.020
Why?
Pneumonia
1
2010
156
0.020
Why?
Transplantation, Heterologous
1
2010
369
0.020
Why?
Carcinoma, Neuroendocrine
1
2009
28
0.020
Why?
Hematinics
1
2008
10
0.020
Why?
Phorbol Esters
1
2008
30
0.020
Why?
Demography
1
2009
162
0.020
Why?
Bone Marrow
1
2010
417
0.020
Why?
Inhibitory Concentration 50
1
2008
64
0.020
Why?
Community Health Services
1
2009
70
0.020
Why?
Postoperative Care
1
2009
232
0.020
Why?
Genes, erbB-1
1
2008
16
0.020
Why?
Cytochrome P-450 CYP3A
1
2008
42
0.020
Why?
Cell Cycle
1
2010
521
0.020
Why?
Blotting, Western
1
2010
832
0.020
Why?
Cytochrome P-450 Enzyme System
1
2008
78
0.020
Why?
Flow Cytometry
1
2010
728
0.020
Why?
Drug Delivery Systems
1
2009
217
0.020
Why?
Exons
1
2009
461
0.020
Why?
Topotecan
1
2007
46
0.020
Why?
Mice, Inbred Strains
1
2008
331
0.020
Why?
ATP-Binding Cassette Transporters
1
2008
142
0.020
Why?
Health Transition
1
2007
2
0.020
Why?
Tamoxifen
1
2008
165
0.020
Why?
Blood Pressure
1
2013
1204
0.020
Why?
Fluoroscopy
1
2007
125
0.020
Why?
Tumor Cells, Cultured
1
2008
1088
0.020
Why?
Academic Medical Centers
1
2009
394
0.020
Why?
Gene Expression Regulation, Enzymologic
1
2008
224
0.020
Why?
Cell Nucleus
1
2009
590
0.020
Why?
Video Recording
1
2007
191
0.020
Why?
Aging
1
2011
668
0.020
Why?
Urogenital Neoplasms
1
2005
17
0.020
Why?
Stem Cells
1
2008
354
0.020
Why?
Mandibular Diseases
1
2005
16
0.020
Why?
Body Mass Index
1
2009
784
0.020
Why?
Polyethylene Glycols
1
2008
396
0.020
Why?
Up-Regulation
1
2008
714
0.020
Why?
Pleural Effusion
1
2004
47
0.020
Why?
Sequence Deletion
1
2005
214
0.020
Why?
Central Nervous System Neoplasms
1
2005
81
0.020
Why?
Gastrointestinal Neoplasms
1
2005
107
0.020
Why?
Genital Neoplasms, Female
1
2005
89
0.020
Why?
Receptors, Endothelin
1
2004
13
0.020
Why?
Antidiarrheals
1
2004
14
0.020
Why?
Research
1
2005
258
0.020
Why?
Biomedical Research
1
2008
355
0.020
Why?
Benzamides
1
2005
219
0.020
Why?
Neoplasm Proteins
1
2008
549
0.020
Why?
Bilirubin
1
2004
129
0.020
Why?
Transforming Growth Factor beta
1
2005
286
0.020
Why?
Genome-Wide Association Study
1
2011
1531
0.020
Why?
Gadolinium DTPA
1
2004
264
0.020
Why?
Hematologic Neoplasms
1
2005
295
0.020
Why?
Biological Availability
1
2002
105
0.010
Why?
Risk
1
2004
700
0.010
Why?
Cytokines
1
2006
755
0.010
Why?
Child
1
2012
6794
0.010
Why?
Severity of Illness Index
1
2007
1781
0.010
Why?
Muscle, Skeletal
1
2004
453
0.010
Why?
Diagnosis, Differential
1
2005
1607
0.010
Why?
Colonic Neoplasms
1
2004
562
0.010
Why?
Phenotype
1
2005
2302
0.010
Why?
Liver
1
2004
1252
0.010
Why?
Anti-Bacterial Agents
1
2004
816
0.010
Why?
Genetic Variation
1
2004
1361
0.010
Why?
Genetic Predisposition to Disease
1
2005
2230
0.010
Why?
Vokes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_